On the Move in Biofuels: Codexis, LS9 add CFOs

September 5, 2012 |

In California, Codexis announced the appointment of David O’Toole as Senior Vice President and Chief Financial Officer, effective September 4, 2012. O’Toole served most recently as Vice President and Chief Financial Officer at Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer and analytical testing services of clinical trial specimens for the pharmaceutical industry. From 2008 to 2009, David was Executive Vice President and Chief Financial Officer of Abraxis Bioscience, Inc., a publicly traded global biotechnology company with a market capitalization of approximately $3 billion.

Also in California, LS9 announced that Jon Foster has joined the Company as its Chief Financial Officer. In this role, Mr. Foster will be responsible for management of the firm’s financial and related functions.  He was previously CFO and Executive Vice President of Corporate Development at Atempo, Inc., an enterprise back-up and archiving software company based in Palo Alto, CA, which was acquired in December 2011. Prior to moving to the Silicon Valley, Mr. Foster served as a deputy director in the White House Office of Science and Technology Policy and serves on the Board of Directors of the California Clean Energy Fund.

Print Friendly, PDF & Email

Tags: ,

Category: Producer News

Thank you for visting the Digest.